A Registry Study on Genetics and Biomarkers of Thoracic Aortic Aneurysm/Dissection
ARSGBTAAD
A Chinese Registry to Determine the Genetic Risk Factors and Serumal Biomarkers for Thoracic Aortic Aneurysm/Dissection
1 other identifier
observational
600
1 country
1
Brief Summary
This is a national registry study to determine genetic risk factor and serial biomarkers of thoracic aortic aneurysm/dissection
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 21, 2016
CompletedFirst Posted
Study publicly available on registry
January 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedJanuary 5, 2017
January 1, 2017
2.5 years
December 21, 2016
January 3, 2017
Conditions
Outcome Measures
Primary Outcomes (23)
Age for each participant
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Gender for each participant
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Height for each participant
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Weight for each participant
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Contact information for each participant
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Past Medical History including disease history, surgical history, and family medical history
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Lifestyle including smoking history and drinking, specify how many years smoking or drinking lasted and detail quantity per day
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Exon sequencing data of each participant
Sequencing will be carried out in an average of 3 months after sample recruiting
Serum biomarker screening data of each participant
Screening will be carried out in an average of 3 months after sample recruiting
The location of Aneurysm/Dissection
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
The size of Aneurysm/Dissection
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:blood lipid
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:blood glucose
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:uric acid
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:urea
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:creatinine
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:C reactive protein
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
blood biochemical index:d dime
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Drug treatment
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Surgery type
These data is collected from the cases' medical record in an average of 1 month after the sample recruiting
Prognosis information: all-cause death
These data is collected during follow-up visit at 3/6/12 months after discharge
Prognosis information: whether recidivation happened
These data is collected during follow-up visit at 3/6/12 months after discharge
Prognosis information including: whether other related disease happened
These data is collected during follow-up visit at 3/6/12 months after discharge
Study Arms (2)
case
control
Eligibility Criteria
case group consists of patients who was diagnosed as thoracic aortic aneurysm/dissection; control group is general population without aortic aneurysm/dissection
You may qualify if:
- Subject who was diagnosed as thoracic aortic aneurysm/dissection by CT angiography, interventional angiography or vascular ultrasound;
- Age is less than 80 years old;
- male and non pregnancy female;
- Subject understands study requirements aand agrees to sign an informed consent form prior to any study procedures.
You may not qualify if:
- Subject has one of the following:
- Pseudoaneurysm;
- Previous infection or trauma in the damaged part of aorta;
- Pregnancy female;
- Participate in other clinical trials in the last 1 months.
- Age and gender are matched with cases;
- No aortic disease was detected by outpatient ultrasound;
- No family history of cardiovascular disease;
- Normal biochemical indicators;
- Criteria for culling, shedding and suspension testing:
- Culling: Unqualified cases and controls. Data of culled subjects can not be used for statistical analysis;
- Shedding: Subject that self withdrawal, loss to follow-up, or quitted by doctors; Reasons for shedding should be indicated for each shed subject.
- Suspension: a) The researchers found significant safety problems or wrong study design; b) Researchers cannot continue clinical research due to funding or management reasons; c) Director ends the study. When suspension happens, all the CRF table should be reserved for future reference.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Anzhen Hospital
Beijing, 100029, China
Related Publications (1)
Fang G, Tian Y, Huang S, Zhang X, Liu Y, Li Y, Du J, Gao S. KLF15 maintains contractile phenotype of vascular smooth muscle cells and prevents thoracic aortic dissection by interacting with MRTFB. J Biol Chem. 2024 May;300(5):107260. doi: 10.1016/j.jbc.2024.107260. Epub 2024 Apr 4.
PMID: 38582447DERIVED
Biospecimen
If a blood specimen is obtained, it will be separated and stored at -80 ℃ as plasma, viable cells, and extracted DNA. If a saliva specimen is obtained, it is stored for DNA. If a tissue specimen is obtained, it will be cut into small pieces and stored at liquid nitrogen.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jie Du, PHD
Beijing Anzhen Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2016
First Posted
January 5, 2017
Study Start
October 1, 2016
Primary Completion
April 1, 2019
Study Completion
October 1, 2019
Last Updated
January 5, 2017
Record last verified: 2017-01